Psychedelic drugs
The latest news about Psychedelic drugs: headlines, AI summaries and the full story from every source.
- Eli Lilly Acquires AtaiBeckley in $2.8 Billion Deal; Cathie Wood Favors Competitor Compass Pathways
- AtaiBeckley shares surge amid reported acquisition talks with Eli Lilly
- Definium Therapeutics Reports Positive Phase 3 Trial Results for DT120 in Major Depressive Disorder
- HHS and VA Memorandum Could Benefit Psychedelic Drug Developers
- Compass Pathways Stock Surges 40% Following White House Executive Order on Psychedelic Therapies
- Trump Signs Executive Order to Expedite Psychedelic Drug Reviews, Including Ibogaine